The Multifaceted Roles of MicroRNAs in Cystic Fibrosis
Open Access
- 17 December 2020
- journal article
- review article
- Published by MDPI AG in Diagnostics
- Vol. 10 (12), 1102
- https://doi.org/10.3390/diagnostics10121102
Abstract
Cystic fibrosis (CF) is a lifelong disorder affecting 1 in 3500 live births worldwide. It is a monogenetic autosomal recessive disease caused by loss-of-function mutations in the gene encoding the chloride channel cystic fibrosis transmembrane conductance regulator (CFTR), the impairment of which leads to ionic disequilibria in exocrine organs. This translates into a chronic multisystemic disease characterized by airway obstruction, respiratory infections, and pancreatic insufficiency as well as hepatobiliary and gastrointestinal dysfunction. Molecular characterization of the mutational heterogeneity of CFTR (affected by more than 2000 variants) improved the understanding and management of CF. However, these CFTR variants are linked to different clinical manifestations and phenotypes, and they affect response to treatments. Expanding evidence suggests that multisystemic disease affects CF pathology via impairing either CFTR or proteins regulated by CFTR. Thus, altering the expression of miRNAs in vivo could constitute an appealing strategy for developing new CF therapies. In this review, we will first describe the pathophysiology and clinical management of CF. Then, we will summarize the current knowledge on altered miRNAs in CF patients, with a focus on the miRNAs involved in the deregulation of CFTR and in the modulation of inflammation. We will highlight recent findings on the potential utility of measuring circulating miRNAs in CF as diagnostic, prognostic, and predictive biomarkers. Finally, we will provide an overview on potential miRNA-based therapeutic approaches.This publication has 126 references indexed in Scilit:
- Gene Mutation in MicroRNA Target Sites of CFTR Gene: A Novel Pathogenetic Mechanism in Cystic Fibrosis?PLOS ONE, 2013
- MicroRNA Expression in Cystic Fibrosis Airway EpitheliumBiomolecules, 2013
- MiR-101 and miR-144 Regulate the Expression of the CFTR Chloride Channel in the LungPLOS ONE, 2012
- A microRNA network regulates expression and biosynthesis of wild-type and ΔF508 mutant cystic fibrosis transmembrane conductance regulatorProceedings of the National Academy of Sciences of the United States of America, 2012
- Synergistic Post-Transcriptional Regulation of the Cystic Fibrosis Transmembrane conductance Regulator (CFTR) by miR-101 and miR-494 Specific BindingPLOS ONE, 2011
- Elevated miR-155 Promotes Inflammation in Cystic Fibrosis by Driving Hyperexpression of Interleukin-8Online Journal of Public Health Informatics, 2011
- Role of Endoplasmic Reticulum Stress in Cystic Fibrosis-Related Airway Inflammatory ResponsesProceedings of the American Thoracic Society, 2010
- Correlation of microRNA levels during hypoxia with predicted target mRNAs through genome-wide microarray analysisBMC Medical Genomics, 2009
- Small‐Molecule Inhibitors of MicroRNA miR‐21 FunctionAngewandte Chemie, 2008
- Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?Nature Reviews Genetics, 2008